Caris Science INC

Providing precision medicine services to patients battling aggressive cancers.

Based in TX

🤖

AI Overview

With $1.3M in lobbying spend across 32 quarterly filings, Caris Science INC is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.

$1.3M
Total Spend
8
Years Active
1
Firms Hired
2
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$160K
2020$160K
2021$160K
2022$160K
2023$160K
2024$160K
2025$160K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, MED, Copyright/Patent

  • Discussion draft by Reps. Bucshon and DeGette to reform the Food & Drug Administration's oversight of diagnostic medical devices and clinical lab services.
  • Medicare coverage and reimbursement of Next Generation Sequencing in advanced cancer. Finalize PAMA reform of clinical lab reimbursement. Proposed National Coverage Decision on Next Generation Sequenc
  • FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. Finalize PAMA reform of Medicare clinical

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.